Results 71 to 80 of about 4,576 (204)

Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay [PDF]

, 2014
Congenital cytomegalovirus (CMV) infection has potentially severe consequences in newborns. The testing of pregnant women for CMV-specific antibodies may be useful for the identification of women at risk of transmitting the infection to the fetus.
C. Vauloup-Fellous, Revello, M. G., M. G. Revello, L. Grangeot-Keros, T. Lazzarotto, Grangeot Keros, L., LAZZAROTTO, TIZIANA, Vauloup Fellous, C.   +7 more
core   +1 more source

Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9317-9325, October 2026.
ABSTRACT Aims To assess the added value of absolute anthropometric targets alongside percentage weight loss in the clinical management of obesity. Materials and Methods The phase 3a, 68‐week REDEFINE 1 trial randomised adults without diabetes with BMI ≥ 30 kg/m2, or ≥ 27 kg/m2 with ≥ 1 obesity‐related complication, to once‐weekly CagriSema 2.4 mg/2.4 ...
Luca Busetto, Cynthia Osorto Contreras, Mikkel Hovden Christensen, Timothy W. Garvey, Deborah B. Horn, Barbara McGowan, Claire Prener Miller, Volker Schnecke, Carel W. le Roux   +8 more
wiley   +1 more source

Anatomical variations of paranasal sinus and ethmoid roof type on computed tomography in patients admitted to the emergency department with migraine headache

Medicine Science, 2020
In this study, we aimed to evaluate the anatomical variations of paranasal sinus on computed tomography (CT) in patients admitted to the emergency department due to migraine.
Sermin Tok Umay, Emine Kadioglu
doaj   +1 more source

The PRIME trial: An investigator‐initiated, multicentre, phase II study of the poly(ADP‐ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)‐mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes

British Journal of Haematology, EarlyView.
Rory M. Shallis, Jennifer VanOudenhove, Namrata Chandhok, Justin Watts, Deepa Jeyakumar, Daniel R. Reed, Jan Phillip Bewersdorf, Diane Durecki, Scott Boerner, Richard F. Little, Steven D. Gore, Jing Li, Xun Bao, Li Chen, Sayak Ghatak, Thomas Prebet, Ranjit S. Bindra, Amer M. Zeidan, Stephanie Halene   +18 more
wiley   +1 more source

From Guidelines to Clinical Practice: Expert Perspectives on Long‐Term Management of Obesity

Obesity, Volume 34, Issue 9, Page 1708-1717, September 2026.
ABSTRACT An international panel of experts from the U.S. and China convened to discuss the 2026 TOS–OMA–OAC Expert Guidance Statement on the Pharmacological Management of Obesity, focusing on emerging evidence, regional considerations, and challenges in translating recommendations into long‐term care.
Hong Chen, Ling Li, Junqing Zhang, Shaihong Zhu, Marc‐André Cornier, Jonathan Q Purnell   +5 more
wiley   +1 more source

P1488: COMBINING ALK2 INHIBITION WITH A MODIFIED ACTIVIN RECEPTOR IIA LIGAND TRAP PROVIDED ADDITIVE BENEFITS IN RESOLVING ANEMIA IN A MOUSE MODEL OF ANEMIA OF INFLAMMATION

HemaSphere, 2023
Chia-Yu Wang, Emiliano Melgar-Bermudez, Diana Welch, Claire Tseng, Ffolliott Fisher, Samuel Cadena, Lorena Lerner, Jasbir Seehra, Jenn Lachey   +8 more
doaj   +1 more source

Early Determinants of Childhood Asthma in Children With Atopic Eczema and High Allergy Risk

Clinical &Experimental Allergy, EarlyView.
Reetta Puisto, Helena Ollila, Samuli Rautava, Erika Isolauri   +3 more
wiley   +1 more source

Oral GLP‐1RA TERN‐601 for Adults With Obesity/Overweight: Placebo‐Controlled, Multiple‐Ascending‐Dose, Phase 1 and 2 Studies

Obesity, Volume 34, Issue 9, Page 1742-1758, September 2026.
ABSTRACT Objective The safety, tolerability, pharmacokinetics, and efficacy of TERN‐601, a once‐daily, oral small‐molecule glucagon‐like peptide‐1 (GLP‐1) receptor agonist, were studied in Phase 1 and 2 clinical studies. Methods The Phase 1 (28‐day) and Phase 2 (12‐week), randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose studies ...
W. Timothy Garvey, Julio Rosenstock, Harold E. Bays, Douglas Denham, Anita Kohli, Melanie Haines, Christopher Jones, Ellen Kwan, Erin Castelloe, Tonya Marmon, Emil Kuriakose, Cara Nelson   +11 more
wiley   +1 more source

P1567: ALK2 INHIBITION LOWERED HEPCIDIN AND LIBERATED SPLEEN IRON FOR ERYTHROPOIESIS IN ANEMIA OF INFLAMMATION

HemaSphere, 2022
C.-Y. Wang, N. Medeiros, E. Melgar-Bermudez, T. Nurse, E. Lema, C. Tseng, F. Fisher, J. Seehra, J. Lachey   +8 more
doaj   +1 more source

Avian influenza overview June–August 2026

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Between 5 June and 28 August 2026, 110 highly pathogenic avian influenza (HPAI) A(H5N1) virus detections were reported in domestic (7) and wild (103) birds in 12 countries in Europe. The number of detections remained at a seasonal low throughout the summer, continuing the decline observed since spring.
European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Union Reference Laboratory for Avian Influenza (EURL), Cyril Barbezange, Mariette Ducatez, Alice Fusaro, Jose L. Gonzales, Thijs Kuiken, Raffaella Melilli, Gražina Mirinavičiūtė, Karl Ståhl, Christoph Staubach, Olov Svartström, Calogero Terregino, Katriina Willgert, Evelyn Alarcón, Lisa Kohnle   +16 more
wiley   +1 more source